191 related articles for article (PubMed ID: 9934950)
21. Venlafaxine drug-drug interactions in clinical practice.
Benazzi F
J Psychiatry Neurosci; 1998 May; 23(3):181-2. PubMed ID: 9595894
[No Abstract] [Full Text] [Related]
22. Spontaneous erections and libido increase associated with venlafaxine.
Bolukbasi O; Akyol A
Eur J Neurol; 1999 Jul; 6(4):527-8. PubMed ID: 10362913
[No Abstract] [Full Text] [Related]
23. Venlafaxine-associated vaginal bleeding.
Linnebur SA; Saseen JJ; Pace WD
Pharmacotherapy; 2002 May; 22(5):652-5. PubMed ID: 12013367
[TBL] [Abstract][Full Text] [Related]
24. Re: Severe anticholinergic side effects with venlafaxine-fluoxetine combination.
Zedkova L; Coupland NJ
Can J Psychiatry; 1998 Jun; 43(5):523. PubMed ID: 9653539
[No Abstract] [Full Text] [Related]
25. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
Silverstone PH; Ravindran A
J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873
[TBL] [Abstract][Full Text] [Related]
26. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
Krol DG; Nolen WA
Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
[TBL] [Abstract][Full Text] [Related]
27. Rapid onset of antidepressant activity with venlafaxine.
Weisler RH; van Meter S
J Clin Psychiatry; 2002 Jun; 63(6):534-5; author reply 535-6. PubMed ID: 12088168
[No Abstract] [Full Text] [Related]
28. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
[TBL] [Abstract][Full Text] [Related]
29. Erotomania induced by venlafaxine: a case study.
Adamou M; Hale AS
Acta Psychiatr Scand; 2003 Apr; 107(4):314-7. PubMed ID: 12662255
[TBL] [Abstract][Full Text] [Related]
30. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
Keller MB; Trivedi MH; Thase ME; Shelton RC; Kornstein SG; Nemeroff CB; Friedman ES; Gelenberg AJ; Kocsis JH; Dunner DL; Dunlop BW; Hirschfeld RM; Rothschild AJ; Ferguson JM; Schatzberg AF; Zajecka JM; Pedersen R; Yan B; Ahmed S; Schmidt M; Ninan PT
Biol Psychiatry; 2007 Dec; 62(12):1371-9. PubMed ID: 17825800
[TBL] [Abstract][Full Text] [Related]
31. Does aripiprazole protect from serotonin syndrome?
Rittmannsberger H; Werl R
Psychiatr Danub; 2012 Mar; 24(1):100-1. PubMed ID: 22447095
[No Abstract] [Full Text] [Related]
32. Less mood switching with venlafaxine?
Mattes JA
Am J Psychiatry; 2006 Sep; 163(9):1642; author reply 1642-3. PubMed ID: 16946194
[No Abstract] [Full Text] [Related]
33. Venlafaxine-fluoxetine-nortriptyline interaction.
Benazzi F
J Psychiatry Neurosci; 1997 Jul; 22(4):278-9. PubMed ID: 9262050
[No Abstract] [Full Text] [Related]
34. Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.
Dursun SM; Devarajan S
Psychopharmacology (Berl); 2001 Feb; 153(4):497-8. PubMed ID: 11243498
[No Abstract] [Full Text] [Related]
35. Addition of olanzapine for treatment-resistant depression.
Pitchot W; Ansseau M
Am J Psychiatry; 2001 Oct; 158(10):1737-8. PubMed ID: 11579017
[No Abstract] [Full Text] [Related]
36. Relatively low doses of cisapride in the treatment of nausea in patients treated with venlafaxine for treatment-refractory depression.
Russell JL
J Clin Psychopharmacol; 1996 Feb; 16(1):35-7. PubMed ID: 8834416
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.
Mines D; Hill D; Yu H; Novelli L
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):367-72. PubMed ID: 15883980
[TBL] [Abstract][Full Text] [Related]
38. Treatment of generalized anxiety disorder with venlafaxine: a series of 11 cases.
Johnson MR; Emmanuel N; Crawford M; Lydiard RB; Villareal G
J Clin Psychopharmacol; 1998 Oct; 18(5):418-9. PubMed ID: 9790161
[No Abstract] [Full Text] [Related]
39. Reassessment of global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.
Tamura RN; Lu Y
J Psychiatr Res; 2003; 37(2):175-6; author reply 176-7. PubMed ID: 12842172
[No Abstract] [Full Text] [Related]
40. A toxic reaction from combining fluoxetine and phentermine.
Bostwick JM; Brown TM
J Clin Psychopharmacol; 1996 Apr; 16(2):189-90. PubMed ID: 8690835
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
